I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Antigen-adjuvant interactions, stability, and immunogenicit..:
Sakshi Bajoria
;
Kawaljit Kaur
;
Ozan S. Kumru
...
http://dx.doi.org/10.1080/21645515.2022.2079346. , 2022
Link:
https://doi.org/10.1080/21645515.2022.2079346
RT Journal T1
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:35022f23ff944bc2b948e4fb228bed37&Exemplar=1&LAN=DE A1 Sakshi Bajoria A1 Kawaljit Kaur A1 Ozan S. Kumru A1 Greta Van Slyke A1 Jennifer Doering A1 Hayley Novak A1 Sergio A. Rodriguez Aponte A1 Neil C. Dalvie A1 Christopher A. Naranjo A1 Ryan S. Johnston A1 Judith Maxwell Silverman A1 Harry Kleanthous A1 J. Christopher Love A1 Nicholas J. Mantis A1 Sangeeta B. Joshi A1 David B. Volkin PB Taylor & Francis Group YR 2022 K1 covid-19 K1 vaccine K1 rbd K1 alum K1 cpg K1 adjuvant K1 formulation K1 stability K1 immunogenicity K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF http://dx.doi.org/10.1080/21645515.2022.2079346 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2022.2079346 DO https://doi.org/10.1080/21645515.2022.2079346 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)